Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flexible implementations of group sequential stopping rules using constrained boundaries.

Bart E Burington1, Scott S Emerson

  • 1Department of Biostatistics, Box 357232, University of Washington, Seattle, Washington, USA.

Biometrics
|February 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same author

Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.

Lancet (London, England)·2026
Same author

Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials.

Diabetes, obesity & metabolism·2026
Same author

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.

Diabetes care·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Group sequential stopping rules enhance clinical trial ethics and efficiency. Constrained boundaries offer flexible interim analysis schedules, aligning with error spending functions for robust hypothesis testing.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Group sequential stopping rules are crucial in clinical trials for patient ethics and resource efficiency.
  • These rules significantly impact the frequentist operating characteristics of hypothesis tests, necessitating careful planning.
  • The precise timing and number of interim analyses are often uncertain during trial design.

Purpose of the Study:

  • To explore the utility of constrained stopping boundaries for implementing flexible group sequential stopping rules.
  • To compare the performance of constrained boundaries across different scales of the test statistic.
  • To demonstrate the equivalence of this approach to the Lan and DeMets (1983) error spending function method when applied to boundary crossing probabilities.

Main Methods:

Related Experiment Videos

  • Investigated the application of constrained stopping boundaries in group sequential trial designs.
  • Evaluated the method's performance using various scales for the test statistic.
  • Compared the constrained boundary approach with the established error spending function methodology.

Main Results:

  • Constrained stopping boundaries provide a flexible framework for managing interim analyses in clinical trials.
  • The choice of scale for the test statistic influences the implementation of constrained boundaries.
  • When applied to boundary crossing probabilities, constrained boundaries are mathematically equivalent to the Lan and DeMets error spending functions.

Conclusions:

  • Constrained stopping boundaries offer a practical and adaptable method for designing group sequential clinical trials.
  • This approach ensures statistical validity while accommodating uncertainties in interim analysis scheduling.
  • The equivalence to error spending functions validates its utility in maintaining trial integrity and efficiency.